At Press Time
The U.S. Patent & Trademark Office has issued a patent to C3 Inc.
for lab-created moissanite gemstones, which the company markets as an alternative
Under the patent, C3 has exclusive rights to manufacture, use and sell
moissanite in the U.S. "Issuance of the patent fulfills an important
part of our strategy to establish synthetic moissanite gemstones as a proprietary,
exclusive product," says Jeff Hunter, president and CEO of C3. (See
page 56 of this issue for more on moissanite.)
by Stacey King Copyright © 1998 by Bond Communications.